Wednesday, July 8, 2026

biotech · Colorectal Cancer · Psoriatic Arthritis, Rheumatoid Arthritis · CRDF

Cardiff Oncology

Cardiff Oncology is a biotech organization headquartered in San Diego, USA. It trades on NYSE under ticker CRDF. Primary therapeutic focus areas include Colorectal Cancer, Psoriatic Arthritis, Rheumatoid Arthritis, Acute

11055 Flintkote Avenue, San Diego, California 92121, US HQ
1999 Founded
51 Employees
Public company Type
CRDF · NYSE Ticker
Company details
Status
Public
HQ
11055 Flintkote Avenue, San Diego, California 92121, US
Founded
1999
Employees
51
Programs
58
Drugs
62
Patents
69
Clinical program

Motivational Interviewing

Phase 2 · other · Diabetes Mellitus

Motivational Interviewing for Diabetes Mellitus is a Phase 2 program (other) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).

← All Cardiff Oncology projects Phase 2 other terminated

Internal code RCUA008

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Cardiff Oncology
Phase
Phase 2
Modality
other
Indication
Diabetes Mellitus
Status
terminated
Trials
1

Clinical trials